Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

Direct human health risks of increased atmospheric carbon dioxide

TA Jacobson, JS Kler, MT Hernke, RK Braun… - Nature …, 2019 - nature.com
Growing evidence suggests that environmentally relevant elevations in CO2 (< 5,000 ppm)
may pose direct risks for human health. Increasing atmospheric CO2 concentrations could …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Cardiovascular disease and COPD: dangerous liaisons?

KF Rabe, JR Hurst, S Suissa - European Respiratory Review, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently occur together and their coexistence is associated with worse outcomes than …

Epidemiology and clinical impact of major comorbidities in patients with COPD

MC Smith, JP Wrobel - International journal of chronic obstructive …, 2014 - Taylor & Francis
Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and
significantly impact on patients' quality of life, exacerbation frequency, and survival. There is …

Managing comorbidities in COPD

G Hillas, F Perlikos, I Tsiligianni… - International journal of …, 2015 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Age and smoking are common risk factors for COPD and other illnesses, often …

Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

D Aune, T Feng, S Schlesinger, I Janszky… - Journal of Diabetes and …, 2018 - Elsevier
Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

COPD and its comorbidities: impact, measurement and mechanisms

NA Negewo, PG Gibson, VM McDonald - Respirology, 2015 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) frequently coexists with other conditions
often known as comorbidities. The prevalence of most of the common comorbid conditions …

Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care

S Roversi, LM Fabbri, DD Sin… - American journal of …, 2016 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health issue with high social and
economic costs. Concomitant chronic cardiac disorders are frequent in patients with COPD …